EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeit

Risk of Post-thrombotic Syndrome after Iliofemoral Thrombosis Treated by Pharmacomechanical Thrombectomy or Catheter Directed Thrombolysis Alone: A Systematic Review and Meta-analysis

Menglin Nie, Minyong Peng, Qiulei Liu, Yida Cao, Chenxu Xing, Zhiyuan Wu, Wayne W Zhang

European Journal of Vascular and Endovascular Surgery · 2026-03 · 71 (3) · 465-474

DOI: 10.1016/j.ejvs.2025.09.019 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2026-03. Verfasst von Menglin Nie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Independent Cardiovascular Research Lab, Chinese Institutes for Medical Research, Capital Medical University, Beijing, China; Department of Vascular …. Hauptthemen laut MEDLINE: Postthrombotic Syndrome, Venous Thrombosis, Thrombectomy, Thrombolytic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This systematic review aimed to compare the effects of pharmacomechanical thrombectomy with catheter directed thrombolysis (CDT) for iliofemoral deep vein thrombosis (DVT) in preventing post-thrombotic syndrome (PTS). DATA SOURCES: PubMed, Embase, and the Cochrane Library from inception until September 2024. REVIEW METHODS: A systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines by searching PubMed, Embase, and the Cochrane Library from inception until September 2024 for studies comparing pharmacomechanical thrombectomy vs. CDT in patients with DVT. The primary outcome was overall risk of PTS, while secondary outcomes included the risks of different PTS classifications and safety outcomes. Safety outcomes included bleeding events, haemoglobinuria, and acute kidney injury (AKI). Risk of bias was evaluated with the ROBINS-I tool. Study quality was assessed by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). RESULTS: Thirteen retrospective cohort studies with 1 742 patients were included. Use of pharmacomechanical thrombectomy for DVT treatment was associated with a lower risk of PTS compared with CDT alone (odds ratio [OR] 0.55, 95% confidence interval [CI] 0.43 - 0.71; p < .001). Pharmacomechanical thrombectomy was associated with a reduced risk of mild PTS (OR 0.56, 95% CI 0.37 - 0.86; p = .008), moderate to severe PTS and or venous ulcers (OR 0.40, 95% CI 0.25 - 0.66; p < .001), and severe PTS and or venous ulcers (OR 0.34, 95% CI 0.19 - 0.59; p = .001). A similar trend was observed for reduced risk of moderate PTS (OR 0.57, 95% CI 0.31 - 1.04; p = .067). Pharmacomechanical thrombectomy was associated with a lower risk of bleeding events compared with CDT (OR 0.58, 95% CI 0.41 - 0.81; p = .001), while haemoglobinuria (OR 20.08, 95% CI 4.57 - 88.19; p < .001) and AKI (OR 3.00, 95% CI 1.12 - 8.01; p = .029) occurred more frequently. GRADE certainty was low or very low for all outcomes. CONCLUSION: Compared with CDT, pharmacomechanical thrombectomy may reduce the risk of PTS of any degree in patients with DVT, while large and well designed studies are needed owing to the very low certainty of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postthrombotic SyndromeVenous ThrombosisThrombectomyThrombolytic TherapyFemoral VeinIliac VeinHumansRisk AssessmentRisk FactorsTreatment OutcomeFibrinolytic Agents

Stichwörter der Autor:innen

Catheter directed thrombolysisIliofemoralPercutaneous aspiration thrombectomyPharmacomechanical thrombectomyPost-thrombotic syndromeVenous thrombosis

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Independent Cardiovascular Research Lab, Chinese Institutes for Medical Research, Capital Medical University, Beijing, China; Department of Vascular Surgery, Anzhen Hospital, Capital Medical University, Beijing, China.
  • Independent Cardiovascular Research Lab, Chinese Institutes for Medical Research, Capital Medical University, Beijing, China.
  • Department of Vascular Surgery, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Independent Cardiovascular Research Lab, Chinese Institutes for Medical Research, Capital Medical University, Beijing, China; Department of Vascular Surgery, Anzhen Hospital, Capital Medical University, Beijing, China;…

Zitieren

APA

Nie, M., Peng, M., Liu, Q., Cao, Y., Xing, C., Wu, Z., & Zhang, W. W. (2026). Risk of Post-thrombotic Syndrome after Iliofemoral Thrombosis Treated by Pharmacomechanical Thrombectomy or Catheter Directed Thrombolysis Alone: A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery, 71(3), 465-474. https://doi.org/10.1016/j.ejvs.2025.09.019

Vancouver

Nie M, Peng M, Liu Q, Cao Y, Xing C, Wu Z, et al. Risk of Post-thrombotic Syndrome after Iliofemoral Thrombosis Treated by Pharmacomechanical Thrombectomy or Catheter Directed Thrombolysis Alone: A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery. 2026;71(3):465-474. doi:10.1016/j.ejvs.2025.09.019

BibTeX
@article{Nie2026,
  author = {Nie, Menglin and Peng, Minyong and Liu, Qiulei and Cao, Yida and Xing, Chenxu and Wu, Zhiyuan and Zhang, Wayne W},
  title = {Risk of Post-thrombotic Syndrome after Iliofemoral Thrombosis Treated by Pharmacomechanical Thrombectomy or Catheter Directed Thrombolysis Alone: A Systematic Review and Meta-analysis},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2026},
  volume = {71},
  number = {3},
  pages = {465--474},
  doi = {10.1016/j.ejvs.2025.09.019}
}
Kostenlos starten →